[Treatment of colostomy evagination in a child with Hirschsprung's disease]

V G Svarich1, V A Svarich2

  • 1St. Petersburg State Pediatric Medical University, St. Petersburg, Russia.

Khirurgiia
|July 1, 2025
PubMed

Insights

Colostomy evagination is a difficult complication after Hirschsprung

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Medical Case Reports

Background:

  • Primary surgery for Hirschsprung's disease is often hindered by significant intestinal enlargement.
  • Colostomy is frequently required initially to normalize colon diameter.
  • Colostomy evagination affects 6.1% of patients, posing complex surgical challenges.

Purpose of the Study:

  • To present a novel surgical approach for treating colostomy evagination.
  • To describe the successful management of a challenging case in a child with subtotal Hirschsprung's disease.

Main Methods:

  • Surgical reconstruction of the evaginated colostomy.
  • Detailed case report of a pediatric patient with subtotal Hirschsprung's disease.

Main Results:

  • Successful surgical correction of colostomy evagination was achieved.
  • The presented technique offered a viable solution for a difficult complication.

Conclusions:

  • Surgical treatment can effectively address colostomy evagination in pediatric Hirschsprung's disease.
  • This case highlights a potentially successful method for managing this challenging complication.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
224
Ostomy Care01:24

Ostomy Care

Introduction
An ostomy is a surgical procedure that creates an artificial opening from the intestines to the outside of the body, allowing for the rerouting of effluent. This opening is known as a stoma. A stoma usually protrudes above the skin surface, appearing pink or red, moist, and round, and it lacks nerve sensations.
There are different types of ostomies, including colostomies, ileostomies, and urostomies:
859
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
163
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
278
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
316
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
243